Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin W Neuman

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Science Advances|April 8, 2026
From vibrations to function: Spectroscopic detection and quantification of π-π stacking in drug-responsive protein complexesNarangerel Altangerel, Esther J Ocola, Benjamin W Neuman, et al.
ACS Central Science|March 1, 2022
Evaluation of SARS-CoV-2 Main Protease Inhibitors Using a Novel Cell-Based AssayWenyue Cao, Chia-Chuan Dean Cho, Zhi Zachary Geng, et al.
Journal of the American Chemical Society|April 14, 2026
Nicotine-Inspired, De Novo-Designed SARS-CoV-2 Main Protease Inhibitors Reveal Unique Chemistry for Covalently Conjugating Both Cysteine and Histidine Residues in the Catalytic DyadSandeep Atla, Veerabhadra Vulupala, Yugendar R Alugubelli, et al.
Nature Communications|February 14, 2026
From nicotine to SARS-CoV-2 antivirals with potent in vivo efficacy and a broad anti-coronavirus spectrumKaustav Khatua, Sandeep Atla, Demonta Coleman, et al.
Biorxiv : the Preprint Server for Biology|April 24, 2023
An Azapeptide Platform in Conjunction with Covalent Warheads to Uncover High-Potency Inhibitors for SARS-CoV-2 Main ProteaseKaustav Khatua, Yugendar R Alugubelli, Kai S Yang, et al.
Antiviral Research|March 30, 2024
Azapeptides with unique covalent warheads as SARS-CoV-2 main protease inhibitorsKaustav Khatua, Yugendar R Alugubelli, Kai S Yang, et al.
The American Journal of Tropical Medicine and Hygiene|September 20, 2021
Case Report: Paucisymptomatic College-Age Population as a Reservoir for Potentially Neutralization-Resistant Severe Acute Respiratory Syndrome Coronavirus 2 VariantsBenjamin W Neuman, Wesley A Brashear, Marcel Brun, et al.
Journal of Virology|August 1, 2024
The harms of promoting the lab leak hypothesis for SARS-CoV-2 origins without evidenceJames Alwine, Felicia Goodrum, Bruce Banfield, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Science Advances|April 8, 2026
From vibrations to function: Spectroscopic detection and quantification of π-π stacking in drug-responsive protein complexesNarangerel Altangerel, Esther J Ocola, Benjamin W Neuman, et al.
ACS Central Science|March 1, 2022
Evaluation of SARS-CoV-2 Main Protease Inhibitors Using a Novel Cell-Based AssayWenyue Cao, Chia-Chuan Dean Cho, Zhi Zachary Geng, et al.
Journal of the American Chemical Society|April 14, 2026
Nicotine-Inspired, De Novo-Designed SARS-CoV-2 Main Protease Inhibitors Reveal Unique Chemistry for Covalently Conjugating Both Cysteine and Histidine Residues in the Catalytic DyadSandeep Atla, Veerabhadra Vulupala, Yugendar R Alugubelli, et al.
Nature Communications|February 14, 2026
From nicotine to SARS-CoV-2 antivirals with potent in vivo efficacy and a broad anti-coronavirus spectrumKaustav Khatua, Sandeep Atla, Demonta Coleman, et al.
Biorxiv : the Preprint Server for Biology|April 24, 2023
An Azapeptide Platform in Conjunction with Covalent Warheads to Uncover High-Potency Inhibitors for SARS-CoV-2 Main ProteaseKaustav Khatua, Yugendar R Alugubelli, Kai S Yang, et al.
Antiviral Research|March 30, 2024
Azapeptides with unique covalent warheads as SARS-CoV-2 main protease inhibitorsKaustav Khatua, Yugendar R Alugubelli, Kai S Yang, et al.
The American Journal of Tropical Medicine and Hygiene|September 20, 2021
Case Report: Paucisymptomatic College-Age Population as a Reservoir for Potentially Neutralization-Resistant Severe Acute Respiratory Syndrome Coronavirus 2 VariantsBenjamin W Neuman, Wesley A Brashear, Marcel Brun, et al.
Journal of Virology|August 1, 2024
The harms of promoting the lab leak hypothesis for SARS-CoV-2 origins without evidenceJames Alwine, Felicia Goodrum, Bruce Banfield, et al.
Pageof 7